Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy" reports on the integration of deep learning and generative AI in radiopharmaceutical medicine, its impact on ...
Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage Detection GAITHERSBURG, Md., July 09, 2026 (GLOBE NEWSWIRE) -- 20/20 ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results